Skip to main content
Clinical Trials/NCT03414099
NCT03414099UnknownNot Applicable

Ketum and Pain Tolerence

Universiti Sains Malaysia1 site in 1 country20 target enrollmentStarted: January 23, 2018Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Enrollment
20
Locations
1
Primary Endpoint
Pain tolerance

Study Overview

Brief Summary

The study aim is to evaluate potential analgesic properties of ketum using the cold pressor task.

Detailed Description

Participants in the proposed study will be individuals who report consuming ketum more than once a day, daily for the past 12 months. The study is a placebo-controlled, double-blind within-subject repeated mesaures design. Participants will ingest a sequence of ketum and placebo drinks prepared by pharmacologists at USM Centre for Drug Research and their pain tolerance will be measured by the cold pressor task after ingesting ketum or placebo.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Other
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Masking Description

Ketum and placebo drinks will be matched for taste and appearence. Each study participant will receive a sequence of ketum and placebo drinks in random order.

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Individuals who report drinking ketum decoction more than once a day, daily for the past 12 months.

Exclusion Criteria

  • (1) tested positive for illicit drug use including morphine, cannabis, methamphetamine, amphetamine, methadone, benzodiazepine and ketamine; (2) have current or previous history of psychological or neurological problems (self-report); (3) have current or previous alcohol use history (self-report); (4) HIV infections; (5) history of chronic liver disease (e.g. cirrhosis, hepatitis A, B, C, etc.) 6) non-alcoholic fatty liver disease; (7) history of coronary heart disease and diabetes; (8) existing chronic pain condition and (9) history of psychiatric disorders. Exclusion criteria for female particiapns: (1) pregnancy, (2) nursing.

Arms & Interventions

Ketum

Experimental

Each participant will consume a sequence of active ketum or placebo drinks. Pain tolerance will be measured using the cold pressor task after consuming each drink.

Intervention: Ketum (Drug)

Placebo

Placebo Comparator

Each participant will consume a sequence of active ketum or placebo drinks. Pain tolerance will be measured using the cold pressor task after consuming each drink.

Intervention: Placebo (Drug)

Outcomes

Primary Outcomes

Pain tolerance

Time Frame: 3 hours

The duration (seconds) participants can keep their hands immersed in the water bath

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Vicknasingam B Kasinather

Professor

Universiti Sains Malaysia

Study Sites (1)

Loading locations...

Similar Trials

Ketum and Pain Tolerence | Clinical Trial